Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.

NCT01735240 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma,
Pharmacokinetics,
Cmax,
Tmax,
λz,
AUC,
Ketoconazole,
Metabolite

Interventions

DRUG: AZD5069
DRUG: Ketoconazole

Sponsor

AstraZeneca